{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:35:39Z","timestamp":1787578539650,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04954-8","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:22:27Z","timestamp":1781576547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["One- versus two-sample fecal immunochemical testing for colorectal cancer screening: a systematic review and meta-analysis of participation, diagnostic performance, and cost-effectiveness"],"prefix":"10.1186","volume":"26","author":[{"given":"Li","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu Ling","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"12","key":"4954_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Reviews Gastroenterol Hepatol. 2019;16(12):713\u201332.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"12","key":"4954_CR2","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2468-1253(19)30329-2","volume":"4","author":"MG Guren","year":"2019","unstructured":"Guren MG. The global challenge of colorectal cancer. Lancet Gastroenterol Hepatol. 2019;4(12):894\u20135.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"4954_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41416-018-0264-x","volume":"119","author":"H Brenner","year":"2018","unstructured":"Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018;119(7):785\u201392.","journal-title":"Br J Cancer"},{"issue":"3","key":"4954_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"1","key":"4954_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"Cancer J Clin"},{"key":"4954_CR6","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs N, Varga O. Socioeconomic and healthcare indicators and colorectal cancer burden: analysis of eurostat and global burden of disease study 2021 Data. Cancers. 2025;17(13).","DOI":"10.3390\/cancers17132075"},{"issue":"6","key":"4954_CR7","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.21037\/jgo-24-318","volume":"15","author":"S Longobardi","year":"2024","unstructured":"Longobardi S. Colorectal cancer: local results and significance in Hungary. J Gastrointest Oncol. 2024;15(6):2552\u201377.","journal-title":"J Gastrointest Oncol"},{"issue":"27","key":"4954_CR8","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.3748\/wjg.v24.i27.2949","volume":"24","author":"KK To","year":"2018","unstructured":"To KK, Tong CW, Wu M, Cho WC. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World J Gastroenterol. 2018;24(27):2949\u201373.","journal-title":"World J Gastroenterol"},{"issue":"9927","key":"4954_CR9","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet (London England). 2014;383(9927):1490\u2013502.","journal-title":"Lancet (London England)"},{"key":"4954_CR10","doi-asserted-by":"crossref","unstructured":"Ebert MP, Reichermeier S, Klug L, Lynen Jansen P, Pox C. Clinical practice guideline: colorectal cancer\u2014diagnosis, treatment, prevention, and long-term follow-up care. Deutsches Arzteblatt international. 2025(Forthcoming).","DOI":"10.3238\/arztebl.m2025.0196"},{"key":"4954_CR11","first-page":"n1855","volume":"374","author":"P Kanth","year":"2021","unstructured":"Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. BMJ (Clinical Res ed). 2021;374:n1855.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"3","key":"4954_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10620-014-3445-3","volume":"60","author":"GP Young","year":"2015","unstructured":"Young GP, Symonds EL, Allison JE, Cole SR, Fraser CG, Halloran SP, Kuipers EJ, Seaman HE. Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci. 2015;60(3):609\u201322.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"4954_CR13","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s10620-024-08718-w","volume":"70","author":"C Senore","year":"2025","unstructured":"Senore C, Doubeni CA, Guittet L. FIT as a Comparator for Evaluating the Effectiveness of New Non-invasive CRC Screening Test. Dig Dis Sci. 2025;70(5):1625\u201336.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"4954_CR14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/jamainternmed.2017.2309","volume":"177","author":"A Katsoula","year":"2017","unstructured":"Katsoula A, Paschos P, Haidich AB, Tsapas A, Giouleme O. Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis. JAMA Intern Med. 2017;177(8):1110\u20138.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"4954_CR15","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1053\/j.gastro.2016.08.053","volume":"152","author":"DJ Robertson","year":"2017","unstructured":"Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;152(5):1217\u2013e12371213.","journal-title":"Gastroenterology"},{"issue":"3","key":"4954_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gutjnl-2011-301583","volume":"62","author":"AH van Roon","year":"2013","unstructured":"van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, Reijerink JC, Mannetje H, van der Togt AC, Habbema JD, et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut. 2013;62(3):409\u201315.","journal-title":"Gut"},{"issue":"8","key":"4954_CR17","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/ajg.2014.168","volume":"109","author":"A Kapidzic","year":"2014","unstructured":"Kapidzic A, Grobbee EJ, Hol L, van Roon AH, van Vuuren AJ, Spijker W, Izelaar K, van Ballegooijen M, Kuipers EJ, van Leerdam ME. Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol. 2014;109(8):1257\u201364.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"4954_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S2468-1253(19)30176-1","volume":"4","author":"EH Schreuders","year":"2019","unstructured":"Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, et al. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study. lancet Gastroenterol Hepatol. 2019;4(8):622\u201331.","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"7","key":"4954_CR19","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"4954_CR20","first-page":"l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Res ed). 2019;366:l4898.","journal-title":"BMJ (Clinical Res ed)"},{"key":"4954_CR21","first-page":"i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical Res ed). 2016;355:i4919.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"5","key":"4954_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ypmed.2013.08.032","volume":"57","author":"J Chubak","year":"2013","unstructured":"Chubak J, Bogart A, Fuller S, Laing SS, Green BB. Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med. 2013;57(5):671\u20138.","journal-title":"Prev Med"},{"issue":"1","key":"4954_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12885-018-4402-x","volume":"18","author":"EG Liles","year":"2018","unstructured":"Liles EG, Perrin N, Rosales AG, Smith DH, Feldstein AC, Mosen DM, Levin TR. Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study. BMC Cancer. 2018;18(1):509.","journal-title":"BMC Cancer"},{"issue":"3","key":"4954_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1590\/s0004-2803.202000000-58","volume":"57","author":"R Mattar","year":"2020","unstructured":"Mattar R, Marques SB, Minata MK, Silva-Etto J, Sakai P, EGH DEM: DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION. Arq Gastroenterol. 2020;57(3):316\u201322.","journal-title":"Arq Gastroenterol"},{"issue":"6","key":"4954_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/CEJ.0000000000000084","volume":"23","author":"DM Mosen","year":"2014","unstructured":"Mosen DM, Liles EG, Feldstein AC, Perrin N, Rosales AG, Keast E, Smith DH. Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT. Eur J cancer prevention: official J Eur Cancer Prev Organisation (ECP). 2014;23(6):516\u201323.","journal-title":"Eur J cancer prevention: official J Eur Cancer Prev Organisation (ECP)"},{"issue":"5","key":"4954_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2011-301917","volume":"62","author":"SL Goede","year":"2013","unstructured":"Goede SL, van Roon AH, Reijerink JC, van Vuuren AJ, Lansdorp-Vogelaar I, Habbema JD, Kuipers EJ, van Leerdam ME, van Ballegooijen M. Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening. Gut. 2013;62(5):727\u201334.","journal-title":"Gut"},{"issue":"1","key":"4954_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/pop.2018.0008","volume":"22","author":"DH Smith","year":"2019","unstructured":"Smith DH, O\u2019Keeffe Rosetti M, Mosen DM, Rosales AG, Keast E, Perrin N, Feldstein AC, Levin TR, Liles EG. Balancing Adherence and Expense: The Cost-Effectiveness of Two-Sample vs One-Sample Fecal Immunochemical Test. Popul health Manage. 2019;22(1):83\u20139.","journal-title":"Popul health Manage"},{"issue":"5","key":"4954_CR28","doi-asserted-by":"publisher","first-page":"e087216","DOI":"10.1136\/bmjopen-2024-087216","volume":"15","author":"H Li","year":"2025","unstructured":"Li H, Fu Y, Xu A, Zhang P, Wang W. Optimising colorectal cancer screening strategies and target populations in budget-constrained regions through cost-effectiveness analysis: a case from eastern China. BMJ open. 2025;15(5):e087216.","journal-title":"BMJ open"},{"issue":"2","key":"4954_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0969141314535388","volume":"21","author":"J Digby","year":"2014","unstructured":"Digby J, McDonald PJ, Strachan JA, Libby G, Steele RJ, Fraser CG. Deprivation and faecal haemoglobin: implications for bowel cancer screening. J Med Screen. 2014;21(2):95\u20137.","journal-title":"J Med Screen"},{"issue":"1","key":"4954_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1515\/cclm-2015-0388","volume":"54","author":"JM Auge","year":"2016","unstructured":"Auge JM, Fraser CG, Rodriguez C, Roset A, Lopez-Ceron M, Grau J, Castells A, Jimenez W. Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients. Clin Chem Lab Med. 2016;54(1):125\u201332.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"4954_CR31","first-page":"322","volume":"30","author":"ME Charlton","year":"2014","unstructured":"Charlton ME, Mengeling MA, Halfdanarson TR, Makki NM, Malhotra A, Klutts JS, Levy BT, Kaboli PJ. Evaluation of a home-based colorectal cancer screening intervention in a rural state. JRural Health. 2014;30(3):322\u201332.","journal-title":"JRural Health"},{"issue":"4","key":"4954_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3322\/caac.21615","volume":"70","author":"S Gupta","year":"2020","unstructured":"Gupta S, Coronado GD, Argenbright K, Brenner AT, Casta\u00f1eda SF, Dominitz JA, Green B, Issaka RB, Levin TR, Reuland DS, et al. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit. Cancer J Clin. 2020;70(4):283\u201398.","journal-title":"Cancer J Clin"},{"key":"4954_CR33","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.2147\/CMAR.S556285","volume":"17","author":"H Xia","year":"2025","unstructured":"Xia H, Wang J, Cheng C, Jiang Q, Guo T, Shen D, Geng H, Zhang T, Duan H. Application of Patient Navigation in Colorectal Cancer Screening: A Scoping Review. Cancer Manage Res. 2025;17:2541\u201351.","journal-title":"Cancer Manage Res"},{"issue":"3","key":"4954_CR34","doi-asserted-by":"publisher","first-page":"e250928","DOI":"10.1001\/jamanetworkopen.2025.0928","volume":"8","author":"GD Coronado","year":"2025","unstructured":"Coronado GD, Petrik AF, Leo MC, Coury J, Durr R, Badicke B, Thompson JH, Edelmann AC, Davis MM. Mailed Outreach and Patient Navigation for Colorectal Cancer Screening Among Rural Medicaid Enrollees: A Cluster Randomized Clinical Trial. JAMA Netw open. 2025;8(3):e250928.","journal-title":"JAMA Netw open"},{"key":"4954_CR35","unstructured":"Symonds E, Anwar S, Bampton P, Cock C, Cole S, Fraser R, Young G. Can fecal immunochemical tests detect sessile serrated adenomas? A one sample compared with a two-sample screening strategy. In: J Gastroenterol Hepatol: 2015: Wiley-Blackwell 111 River St, Hoboken 07030\u2009\u2013\u20095774, NJ USA. 2015;30:75."},{"issue":"7","key":"4954_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.7326\/M18-0244","volume":"169","author":"K Selby","year":"2018","unstructured":"Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, et al. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med. 2018;169(7):439\u201347.","journal-title":"Ann Intern Med"},{"key":"4954_CR37","doi-asserted-by":"crossref","unstructured":"Baldwin T, Verma A. P392 How has the transition from FOBt to FIT changed the BCSP colonoscopy service? In. BMJ Publishing Group. 2021.","DOI":"10.1136\/gutjnl-2020-bsgcampus.466"},{"key":"4954_CR38","doi-asserted-by":"crossref","unstructured":"Chiu H-M, Lee Y-C, Chou C-k, Wu M-SJG. Mo1929 comparison of one-day and two-day sampling on detection of significant colorectal neoplasm by fecal immunochemical test-preliminary results from a population-based randomized controlled trial. 2015;148(4):S\u2013742.","DOI":"10.1016\/S0016-5085(15)32538-5"},{"key":"4954_CR39","doi-asserted-by":"crossref","unstructured":"Moosavi S, Enns R, Gentile L, Gondara L, McGahan C, Telford J. Comparison of one versus two fecal immunochemical tests in the detection of colorectal neoplasia in a population-based colorectal cancer screening program. Can J Gastroenterol Hepatol. 2016;2016:5914048.","DOI":"10.1155\/2016\/5914048"},{"issue":"7","key":"4954_CR40","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1136\/gutjnl-2015-310102","volume":"66","author":"U Haug","year":"2017","unstructured":"Haug U, Grobbee EJ, Lansdorp-Vogelaar I, Spaander MCW, Kuipers EJ. Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended? Gut. 2017;66(7):1262\u20137.","journal-title":"Gut"},{"key":"4954_CR41","unstructured":"Young G, Symonds E. How many samples are needed when screening with faecal immunochemical tests for colorectal cancer? In: J Gastroenterol Hepatol: 2016: Wiley-Blackwell 111 River ST, Hoboken 07030\u2009\u2013\u20095774, NJ USA. 2016;31:62\u20133."},{"key":"4954_CR42","doi-asserted-by":"crossref","unstructured":"Young GP, Woodman RJ, Symonds E. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold. BMJ open Gastroenterol. 2020;7(1).","DOI":"10.1136\/bmjgast-2020-000517"},{"issue":"5","key":"4954_CR43","doi-asserted-by":"publisher","first-page":"e048156","DOI":"10.1136\/bmjopen-2020-048156","volume":"12","author":"D Cenin","year":"2022","unstructured":"Cenin D, Li P, Wang J, de Jonge L, Yan B, Tao S, Lansdorp-Vogelaar I. Optimising colorectal cancer screening in Shanghai, China: a modelling study. BMJ open. 2022;12(5):e048156.","journal-title":"BMJ open"},{"issue":"5","key":"4954_CR44","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/apt.18459","volume":"61","author":"CJ Crooks","year":"2025","unstructured":"Crooks CJ, West J, Jones J, Hamilton W, Bailey SER, Abel G, Banerjea A, Rees CJ, Tamm A, Nicholson BD, et al. COLOFIT: Development and Internal-External Validation of Models Using Age, Sex, Faecal Immunochemical and Blood Tests to Optimise Diagnosis of Colorectal Cancer in Symptomatic Patients. Aliment Pharmacol Ther. 2025;61(5):852\u201364.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04954-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:14:21Z","timestamp":1787577261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04954-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4954"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04954-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"520"}}